{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:10:32Z","timestamp":1790892632955,"version":"4.1.0"},"reference-count":76,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Valproic acid (VPA)-induced hepatotoxicity is among the most common\nand severe adverse drug reactions, limiting its clinical application. Recent studies have suggested\nthat activating the farnesoid X receptor (FXR) could be a promising therapeutic approach to alleviate\nVPA-induced hepatotoxicity; however, related research remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study aims to comprehensively investigate the mechanisms underlying FXR activation\nby obeticholic acid (OCA) for the treatment of VPA-induced hepatotoxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Network pharmacology was performed to identify potential targets and pathways underlying\nthe amelioration of VPA-induced hepatotoxicity by OCA. The identified pathways were validated\nthrough GEO data analysis, and the affinities between OCA and potential key targets were\npredicted using molecular docking as well as molecular dynamics simulations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 462 targets associated with VPA-induced hepatotoxicity and 288 targets of\nOCA were identified, with 81 shared targets. KEGG pathway and GO enrichment analysis indicated\nthat the effect of OCA on VPA-induced hepatotoxicity primarily involved lipid metabolism, as\nwell as oxidative stress and inflammation. The results from GEO data analysis, molecular docking,\nand molecular dynamics simulations revealed a close association between bile secretion, the\nPPAR signaling pathway, and the treatment of VPA-induced hepatotoxicity by OCA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our findings suggest that OCA exhibits potential therapeutic efficacy against VPAinduced\nhepatotoxicity through multiple targets and pathways, thereby highlighting the therapeutic\npotential of FXR as a target for treating VPA-induced hepatotoxicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115734099324138240823041016","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T07:38:10Z","timestamp":1725435490000},"page":"1057-1069","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanisms Underlying the Protective Effects of Obeticholic Acid-activated FXR in Valproic Acid-induced Hepatotoxicity via Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2978-8308","authenticated-orcid":true,"given":"Ya'nan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Jiangsu Cancer Hospital &amp; Jiangsu Institute of Cancer Research &amp; The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9867-3486","authenticated-orcid":true,"given":"Jingkai","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Immuno-Oncology, Beckman Research Institute City of Hope National Medical Center, Duarte CA, 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-9192","authenticated-orcid":true,"given":"Shansen","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Jiangsu Simcere Pharmaceutical Co., Ltd, Nanjing, 210042, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Jiangsu Cancer Hospital &amp; Jiangsu Institute of Cancer Research &amp; The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/JCP.0000000000001689","volume":"43","author":"Wong Y.C.J.","year":"2023","unstructured":"Wong Y.C.J.; Fan J.; Wan A.; Mihic T.; Gnyra M.; Valproic acid\u2013associated hyperammonemia. J Clin Psychopharmacol  2023,43(3),283-294","journal-title":"J Clin Psychopharmacol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"23m15008","DOI":"10.4088\/JCP.23m15008","volume":"85","author":"Grosu C.","year":"2024","unstructured":"Grosu C.; Hatoum W.; Piras M.; Laaboub N.; Ranjbar S.; Gamma F.; Plessen K.J.; Gunten A.; Preisig M.; Conus P.; Eap C.B.; Associations of valproate doses with weight gain in adult psychiatric patients. J Clin Psychiatry  2024,85(2),23m15008","journal-title":"J Clin Psychiatry"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"103967","DOI":"10.1016\/j.etap.2022.103967","volume":"95","author":"Ezhilarasan D.","year":"2022","unstructured":"Ezhilarasan D.; Mani U.; Valproic acid induced liver injury: An insight into molecular toxicological mechanism. Environ Toxicol Pharmacol  2022,95,103967","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"116438","DOI":"10.1016\/j.bcp.2024.116438","volume":"227","author":"Wang M.L.","year":"2024","unstructured":"Wang M.L.; Zhang Y.J.; He D.L.; Li T.; Zhao M.M.; Zhao L.M.; Inhibition of PLA2G4A attenuated valproic acid- induced lysosomal membrane permeabilization and restored impaired autophagic flux: Implications for hepatotoxicity. Biochem Pharmacol  2024,227,116438","journal-title":"Biochem Pharmacol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"115538","DOI":"10.1016\/j.jpba.2023.115538","volume":"234","author":"Wang W.J.","year":"2023","unstructured":"Wang W.J.; Zhao Y.T.; Dai H.R.; Zhang Y.Y.; Wang J.; Guo H.L.; Ding X.S.; Chen F.; Successful LC-MS\/MS assay development and validation for determination of valproic acid and its metabolites supporting proactive pharmacovigilance. J Pharm Biomed Anal  2023,234,115538","journal-title":"J Pharm Biomed Anal"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1048728","DOI":"10.3389\/fphar.2022.1048728","volume":"13","author":"Ma Y.","year":"2022","unstructured":"Ma Y.; Wang M.; Guo S.; Li T.; Liu X.; Zhao L.; The serum acylcarnitines profile in epileptic children treated with valproic acid and the protective roles of peroxisome proliferator-activated receptor a activation in valproic acid-induced liver injury. Front Pharmacol  2022,13,1048728","journal-title":"Front Pharmacol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1080\/03602530600959433","volume":"38","author":"Chang T.K.H.","year":"2006","unstructured":"Chang T.K.H.; Abbott F.S.; Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity. Drug Metab Rev  2006,38(4),627-639","journal-title":"Drug Metab Rev"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"113860","DOI":"10.1016\/j.bcp.2020.113860","volume":"177","author":"Gr\u00fcnig D.","year":"2020","unstructured":"Gr\u00fcnig D.; Szabo L.; Marbet M.; Kr\u00e4henb\u00fchl S.; Valproic acid affects fatty acid and triglyceride metabolism in HepaRG cells exposed to fatty acids by different mechanisms. Biochem Pharmacol  2020,177,113860","journal-title":"Biochem Pharmacol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ana.20074","volume":"55","author":"Luef G.J.","year":"2004","unstructured":"Luef G.J.; Waldmann M.; Sturm W.; Naser A.; Trinka E.; Unterberger I.; Bauer G.; Lechleitner M.; Valproate therapy and nonalcoholic fatty liver disease. Ann Neurol  2004,55(5),729-732","journal-title":"Ann Neurol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3109\/03009734.2010.545898","volume":"116","author":"Lampon N.","year":"2011","unstructured":"Lampon N.; Tutor J.C.; A preliminary investigation on the possible association between diminished copper availability and non-alcoholic fatty liver disease in epileptic patients treated with valproic acid. Ups J Med Sci  2011,116(2),148-154","journal-title":"Ups J Med Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3389\/fphar.2019.00819","volume":"10","author":"Xu S.","year":"2019","unstructured":"Xu S.; Chen Y.; Ma Y.; Liu T.; Zhao M.; Wang Z.; Zhao L.; Lipidomic profiling reveals disruption of lipid metabolism in valproic acid-induced hepatotoxicity. Front Pharmacol  2019,10,819","journal-title":"Front Pharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.1111\/jcmm.14464","volume":"23","author":"Li R.","year":"2019","unstructured":"Li R.; Qin X.; Liang X.; Liu M.; Zhang X.; Lipidomic characteristics and clinical findings of epileptic patients treated with valproic acid. J Cell Mol Med  2019,23(9),6017-6023","journal-title":"J Cell Mol Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2131\/jts.49.69","volume":"49","author":"Kitahara G.","year":"2024","unstructured":"Kitahara G.; Higashisaka K.; Nakamoto Y.; Yamamoto R.; Okuno W.; Serizawa M.; Sakahashi Y.; Tsujino H.; Haga Y.; Tsutsumi Y.; Valproic acid elevates HIF-1\u03b1-mediated <i>CGB<\/i> expression and suppresses glucose uptake in BeWo cells. J Toxicol Sci  2024,49(2),69-77","journal-title":"J Toxicol Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/15563650.2024.2366920","volume":"62","author":"Ma L.","year":"2024","unstructured":"Ma L.; Zhu J.; Kong X.; Chen L.; Du J.; Yang L.; Wang D.; Wang Z.; Influence of the glutamate-glutamine cycle on valproic acid-associated hepatotoxicity in pediatric patients with epilepsy. Clin Toxicol (Phila)  2024,62(6),364-371","journal-title":"Clin Toxicol (Phila)"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"113669","DOI":"10.1016\/j.bcp.2019.113669","volume":"170","author":"Chen Y.","year":"2019","unstructured":"Chen Y.; Zhou J.; Xu S.; Liu M.; Wang M.; Ma Y.; Zhao M.; Wang Z.; Guo Y.; Zhao L.; Association between the perturbation of bile acid homeostasis and valproic acid-induced hepatotoxicity. Biochem Pharmacol  2019,170,113669","journal-title":"Biochem Pharmacol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1399829","DOI":"10.3389\/fphar.2024.1399829","volume":"15","author":"Xiao Y.","year":"2024","unstructured":"Xiao Y.; Jia Y.; Liu W.; Niu C.; Mai Z.; Dong J.; Zhang X.; Yuan Z.; Ji P.; Wei Y.; Hua Y.; Pulsatilla decoction alleviates DSS-induced UC by activating FXR-ASBT pathways to ameliorate disordered bile acids homeostasis. Front Pharmacol  2024,15,1399829","journal-title":"Front Pharmacol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e00518-22","DOI":"10.1128\/spectrum.00518-22","volume":"10","author":"Ye X.","year":"2022","unstructured":"Ye X.; Huang D.; Dong Z.; Wang X.; Ning M.; Xia J.; Shen S.; Wu S.; Shi Y.; Wang J.; Wan X.; FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Lactobacillus Strains. Microbiol Spectr  2022,10(5),e00518-22","journal-title":"Microbiol Spectr"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","volume":"33","author":"Zheng X.","year":"2021","unstructured":"Zheng X.; Chen T.; Jiang R.; Zhao A.; Wu Q.; Kuang J.; Sun D.; Ren Z.; Li M.; Zhao M.; Wang S.; Bao Y.; Li H.; Hu C.; Dong B.; Li D.; Wu J.; Xia J.; Wang X.; Lan K.; Rajani C.; Xie G.; Lu A.; Jia W.; Jiang C.; Jia W.; Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab  2021,33(4),791-803.e7","journal-title":"Cell Metab"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s40168-023-01709-5","volume":"11","author":"Xu H.","year":"2023","unstructured":"Xu H.; Fang F.; Wu K.; Song J.; Li Y.; Lu X.; Liu J.; Zhou L.; Yu W.; Yu F.; Gao J.; Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia. Microbiome  2023,11(1),262","journal-title":"Microbiome"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jhep.2023.07.034","volume":"79","author":"Adorini L.","year":"2023","unstructured":"Adorini L.; Trauner M.; FXR agonists in NASH treatment. J Hepatol  2023,79(5),1317-1331","journal-title":"J Hepatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"122182","DOI":"10.1016\/j.lfs.2023.122182","volume":"334","author":"Aljarboa A.S.","year":"2023","unstructured":"Aljarboa A.S.; Alhusaini A.M.; Sarawi W.S.; Mohammed R.; Ali R.A.; Hasan I.H.; The implication of LPS\/TLR4 and FXR receptors in hepatoprotective efficacy of indole-3-acetic acid and chenodeoxycholic acid. Life Sci  2023,334,122182","journal-title":"Life Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1124\/mol.119.118646","volume":"97","author":"Gai Z.","year":"2020","unstructured":"Gai Z.; Krajnc E.; Samodelov S.L.; Visentin M.; Kullak-Ublick G.A.; Obeticholic acid ameliorates valproic acid\u2013induced hepatic steatosis and oxidative stress. Mol Pharmacol  2020,97(5),314-323","journal-title":"Mol Pharmacol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jhep.2021.03.020","volume":"75","author":"Kremoser C.","year":"2021","unstructured":"Kremoser C.; FXR agonists for NASH: How are they different and what difference do they make? J Hepatol  2021,75(1),12-15","journal-title":"J Hepatol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jhep.2022.10.007","volume":"78","author":"Nevens F.","year":"2023","unstructured":"Nevens F.; Trauner M.; Manns M.P.; Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases\u2020. J Hepatol  2023,78(2),430-441","journal-title":"J Hepatol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"102425","DOI":"10.1016\/j.coph.2023.102425","volume":"74","author":"Lazzara F.","year":"2024","unstructured":"Lazzara F.; Conti F.; Giuffrida E.; Eandi C.M.; Drago F.; Platania C.B.M.; Bucolo C.; Integrating network pharmacology: The next-generation approach in ocular drug discovery. Curr Opin Pharmacol  2024,74,102425","journal-title":"Curr Opin Pharmacol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-1-0716-3662-6_13","volume":"2761","author":"Latha S.","year":"2024","unstructured":"Latha S.; Role of network pharmacology in prediction of mechanism of neuroprotective compounds. Methods Mol Biol  2024,2761,159-179","journal-title":"Methods Mol Biol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.3390\/ijms25137077","volume":"25","author":"Huang H.","year":"2024","unstructured":"Huang H.; Li X.; Wu W.; Liu C.; Shao Y.; Wu X.; Fu J.; Cordycepin enhances the therapeutic efficacy of doxorubicin in treating triple-negative breast cancer. Int J Mol Sci  2024,25(13),7077","journal-title":"Int J Mol Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e5890","DOI":"10.1002\/bmc.5890","volume":"38","author":"Lei H.","year":"2024","unstructured":"Lei H.; Zhang H.; Yu Y.; Yu X.; Guo M.; Yuan Y.; Exploring potential targets and pathways of toxicity attenuation through serum pharmacochemistry and network pharmacology in the processing of aconiti lateralis radix praeparata. Biomed Chromatogr  2024,38(8),e5890","journal-title":"Biomed Chromatogr"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","volume":"13","author":"Agu P.C.","year":"2023","unstructured":"Agu P.C.; Afiukwa C.A.; Orji O.U.; Ezeh E.M.; Ofoke I.H.; Ogbu C.O.; Ugwuja E.I.; Aja P.M.; Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep  2023,13(1),13398","journal-title":"Sci Rep"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"105454","DOI":"10.1016\/j.compbiomed.2022.105454","volume":"145","author":"Wang Y.","year":"2022","unstructured":"Wang Y.; Yuan Y.; Wang W.; He Y.; Zhong H.; Zhou X.; Chen Y.; Cai X.J.; Liu L.; Mechanisms underlying the therapeutic effects of Qingfeiyin in treating acute lung injury based on GEO datasets, network pharmacology and molecular docking. Comput Biol Med  2022,145,105454","journal-title":"Comput Biol Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"106840","DOI":"10.1016\/j.bioorg.2023.106840","volume":"140","author":"Sun Z.","year":"2023","unstructured":"Sun Z.; Wang Y.; Pang X.; Wang X.; Zeng H.; Mechanisms of polydatin against spinal cord ischemia\u2013reperfusion injury based on network pharmacology, molecular docking and molecular dynamics simulation. Bioorg Chem  2023,140,106840","journal-title":"Bioorg Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2220558","DOI":"10.1080\/14756366.2023.2220558","volume":"38","author":"Xu Y.","year":"2023","unstructured":"Xu Y.; Zou Y.; Zhou S.; Niu M.M.; Zhang Y.; Li J.; Xu Z.; Yang L.; Discovery of potent heat shock protein 90 (Hsp90) inhibitors: Structure-based virtual screening, molecular dynamics simulation, and biological evaluation. J Enzyme Inhib Med Chem  2023,38(1),2220558","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1147360","DOI":"10.3389\/fphar.2023.1147360","volume":"14","author":"Yu Y.","year":"2023","unstructured":"Yu Y.; Zhou M.; Long X.; Yin S.; Hu G.; Yang X.; Jian W.; Yu R.; Study on the mechanism of action of colchicine in the treatment of coronary artery disease based on network pharmacology and molecular docking technology. Front Pharmacol  2023,14,1147360","journal-title":"Front Pharmacol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"Van Der Spoel D.","year":"2005","unstructured":"Van Der Spoel D.; Lindahl E.; Hess B.; Groenhof G.; Mark A.E.; Berendsen H.J.C.; GROMACS: Fast, flexible, and free. J Comput Chem  2005,26(16),1701-1718","journal-title":"J Comput Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1007\/s00204-024-03762-x","volume":"98","author":"Xiong A.","year":"2024","unstructured":"Xiong A.; Lu L.; Jiang K.; Wang X.; Chen Y.; Wang X.; Zhang W.; Zhuge Y.; Huang W.; Li L.; Liao Q.; Yang F.; Liu P.; Ding L.; Wang Z.; Yang L.; Functional metabolomics characterizes the contribution of farnesoid X receptor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Arch Toxicol  2024,98(8),2557-2576","journal-title":"Arch Toxicol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"115777","DOI":"10.1016\/j.biopha.2023.115777","volume":"168","author":"Azizsoltani A.","year":"2023","unstructured":"Azizsoltani A.; Hatami B.; Zali M.R.; Mahdavi V.; Baghaei K.; Alizadeh E.; Obeticholic acid-loaded exosomes attenuate liver fibrosis through dual targeting of the FXR signaling pathway and ECM remodeling. Biomed Pharmacother  2023,168,115777","journal-title":"Biomed Pharmacother"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/liv.15767","volume":"44","author":"Di Pasqua L.G.","year":"2024","unstructured":"Di Pasqua L.G.; Cagna M.; Palladini G.; Croce A.C.; Cadamuro M.; Fabris L.; Perlini S.; Adorini L.; Ferrigno A.; Vairetti M.;  agonists -787 and  increase  and inhibit liver steatosis and inflammation in diet-induced ob\/ob mouse model of . Liver Int  2024,44(1),214-227","journal-title":"Liver Int"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.tem.2010.06.009","volume":"21","author":"Lefebvre P.","year":"2010","unstructured":"Lefebvre P.; Benomar Y.; Staels B.; Retinoid X receptors: Common heterodimerization partners with distinct functions. Trends Endocrinol Metab  2010,21(11),676-683","journal-title":"Trends Endocrinol Metab"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.3390\/cancers13143409","volume":"13","author":"Wawruszak A.","year":"2021","unstructured":"Wawruszak A.; Halasa M.; Okon E.; Kukula-Koch W.; Stepulak A.; Valproic acid and breast cancer: State of the art in 2021. Cancers (Basel)  2021,13(14),3409","journal-title":"Cancers (Basel)"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"120976","DOI":"10.1016\/j.lfs.2022.120976","volume":"309","author":"Du S.","year":"2022","unstructured":"Du S.; Wang X.; Hu Y.; Zhang S.; Wang D.; Zhang Q.; Liu S.; Valproic acid regulates MIEF1 through MST2-HIPPO to suppress breast cancer growth. Life Sci  2022,309,120976","journal-title":"Life Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13046-019-1160-9","volume":"38","author":"Lin T.","year":"2019","unstructured":"Lin T.; Ren Q.; Zuo W.; Jia R.; Xie L.; Lin R.; Zhao H.; Chen J.; Lei Y.; Wang P.; Dong H.; Huang L.; Cai J.; Peng Y.; Yu Z.; Tan J.; Wang S.; Valproic acid exhibits anti-tumor activity selectively against EGFR\/ErbB2\/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs. J Exp Clin Cancer Res  2019,38(1),150","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"155459","DOI":"10.1016\/j.phymed.2024.155459","volume":"126","author":"Chen Z.","year":"2024","unstructured":"Chen Z.; Wu F.; Li J.; Dong J.; He H.; Li X.; Lu Q.; Zhang W.; Shao C.; Yao Z.; Lin N.; Ye Z.; Xu J.; Li H.; Investigating the synergy of Shikonin and Valproic acid in inducing apoptosis of osteosarcoma cells via ROS-mediated EGR1 expression. Phytomedicine  2024,126,155459","journal-title":"Phytomedicine"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"110084","DOI":"10.1016\/j.abb.2024.110084","volume":"758","author":"Emad D.","year":"2024","unstructured":"Emad D.; Bayoumi A.M.A.; Gebril S.M.; Ali D.M.E.; Waz S.; Modulation of keap-1\/Nrf2\/HO-1 and NF-\u0138b\/caspase-3 signaling pathways by dihydromyricetin ameliorates sodium valproate-induced liver injury. Arch Biochem Biophys  2024,758,110084","journal-title":"Arch Biochem Biophys"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"6563","DOI":"10.1158\/0008-5472.CAN-06-0814","volume":"66","author":"Kawai Y.","year":"2006","unstructured":"Kawai Y.; Arinze I.J.; Valproic acid-induced gene expression through production of reactive oxygen species. Cancer Res  2006,66(13),6563-6569","journal-title":"Cancer Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1007\/s00210-023-02494-6","volume":"396","author":"Arslan M.A.","year":"2023","unstructured":"Arslan M.A.; Tun\u00e7el \u00d6.K.; Bilgici B.; Karaustao\u011flu A.; G\u00fcmr\u00fck\u00e7\u00fco\u011flu T.\u0130.; Increased levels of lipid and protein oxidation in rat prefrontal cortex after treatment by lithium, valproic acid, and olanzapine. Naunyn Schmiedebergs Arch Pharmacol  2023,396(10),2721-2728","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11064-017-2370-1","volume":"43","author":"Kawada K.","year":"2018","unstructured":"Kawada K.; Mimori S.; Implication of endoplasmic reticulum stress in autism spectrum disorder. Neurochem Res  2018,43(1),147-152","journal-title":"Neurochem Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"152585","DOI":"10.1016\/j.tox.2020.152585","volume":"445","author":"Ma L.","year":"2020","unstructured":"Ma L.; Wang Y.; Chen X.; Zhao L.; Guo Y.; Involvement of CYP2E1-ROS-CD36\/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro. Toxicology  2020,445,152585","journal-title":"Toxicology"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1053\/j.gastro.2019.04.023","volume":"157","author":"Torres S.","year":"2019","unstructured":"Torres S.; Baulies A.; Insausti-Urkia N.; Alarc\u00f3n-Vila C.; Fucho R.; Solsona-Vilarrasa E.; N\u00fa\u00f1ez S.; Robles D.; Ribas V.; Wakefield L.; Grompe M.; Lucena M.I.; Andrade R.J.; Win S.; Aung T.A.; Kaplowitz N.; Garc\u00eda-Ruiz C.; Fern\u00e1ndez-Checa J.C.; Endoplasmic Reticulum Stress-Induced Upregulation of STARD1 Promotes Acetaminophen-Induced Acute Liver Failure. Gastroenterology  2019,157(2),552-568","journal-title":"Gastroenterology"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"106399","DOI":"10.1016\/j.ejps.2023.106399","volume":"183","author":"Schiavo A.","year":"2023","unstructured":"Schiavo A.; Maldonado C.; V\u00e1zquez M.; Fagiolino P.; Troc\u00f3niz I.F.; Ibarra M.; Quantitative systems pharmacology Model to characterize valproic acid-induced hyperammonemia and the effect of L-carnitine supplementation. Eur J Pharm Sci  2023,183,106399","journal-title":"Eur J Pharm Sci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1080\/15376516.2021.1943089","volume":"31","author":"Celik E.","year":"2021","unstructured":"Celik E.; Tunali S.; Gezginci-Oktayoglu S.; Bolkent S.; Can A.; Yanardag R.; Vitamin U prevents valproic acid-induced liver injury through supporting enzymatic antioxidant system and increasing hepatocyte proliferation triggered by inflammation and apoptosis. Toxicol Mech Methods  2021,31(8),600-608","journal-title":"Toxicol Mech Methods"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1007\/s11033-021-06428-4","volume":"48","author":"Khodayar M.J.","year":"2021","unstructured":"Khodayar M.J.; Kalantari H.; Khorsandi L.; Ahangar N.; Samimi A.; Alidadi H.; Taurine attenuates valproic acid-induced hepatotoxicity via modulation of RIPK1\/RIPK3\/MLKL-mediated necroptosis signaling in mice. Mol Biol Rep  2021,48(5),4153-4162","journal-title":"Mol Biol Rep"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s10695-022-01130-z","volume":"48","author":"Xu J.","year":"2022","unstructured":"Xu J.; Yao X.; Li X.; Xie S.; Chi S.; Zhang S.; Cao J.; Tan B.; Farnesoid X receptor regulates PIK\/AKT\/mTOR signaling pathway, lipid metabolism, and immune response in hybrid grouper. Fish Physiol Biochem  2022,48(6),1521-1538","journal-title":"Fish Physiol Biochem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3892\/ijmm.2018.3715","volume":"42","author":"Liu Y.","year":"2018","unstructured":"Liu Y.; Song A.; Yang X.; Zhen Y.; Chen W.; Yang L.; Wang C.; Ma H.; Farnesoid X receptor agonist decreases lipid accumulation by promoting hepatic fatty acid oxidation in db\/db mice. Int J Mol Med  2018,42(3),1723-1731","journal-title":"Int J Mol Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"e12812","DOI":"10.1111\/jpi.12812","volume":"73","author":"Liu S.","year":"2022","unstructured":"Liu S.; Kang W.; Mao X.; Ge L.; Du H.; Li J.; Hou L.; Liu D.; Yin Y.; Liu Y.; Huang K.; Melatonin mitigates aflatoxin B1-induced liver injury via modulation of gut microbiota\/intestinal FXR\/liver TLR4 signaling axis in mice. J Pineal Res  2022,73(2),e12812","journal-title":"J Pineal Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"114244","DOI":"10.1016\/j.biopha.2023.114244","volume":"159","author":"Savova M.S.","year":"2023","unstructured":"Savova M.S.; Mihaylova L.V.; Tews D.; Wabitsch M.; Georgiev M.I.; Targeting PI3K\/AKT signaling pathway in obesity. Biomed Pharmacother  2023,159,114244","journal-title":"Biomed Pharmacother"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.7150\/ijbs.92337","volume":"20","author":"Wu Y.","year":"2024","unstructured":"Wu Y.; Yan Q.; Yue S.; Pan L.; Yang D.; Tao L.; Wei Z.; Rong F.; Qian C.; Han M.; Zuo F.; Yang J.; Xu J.; Shi Z.; Du J.; Chen Z.; Xu T.; NUP85 alleviates lipid metabolism and inflammation by regulating PI3K\/AKT signaling pathway in nonalcoholic fatty liver disease. Int J Biol Sci  2024,20(6),2219-2235","journal-title":"Int J Biol Sci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"110876","DOI":"10.1016\/j.intimp.2023.110876","volume":"124","author":"Fang Z.","year":"2023","unstructured":"Fang Z.; Yushanjiang F.; Wang G.; Zheng X.; Jiang X.; Germacrone mitigates cardiac remodeling by regulating PI3K\/AKT-mediated oxidative stress, inflammation, and apoptosis. Int Immunopharmacol  2023,124(Pt A),110876","journal-title":"Int Immunopharmacol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","volume":"24","author":"Steinberg G.R.","year":"2023","unstructured":"Steinberg G.R.; Hardie D.G.; New insights into activation and function of the AMPK. Nat Rev Mol Cell Biol  2023,24(4),255-272","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.taap.2016.12.019","volume":"316","author":"Choi Y.J.","year":"2017","unstructured":"Choi Y.J.; Lee K.Y.; Jung S.H.; Kim H.S.; Shim G.; Kim M.G.; Oh Y.K.; Oh S.H.; Jun D.W.; Lee B.H.; Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice. Toxicol Appl Pharmacol  2017,316,74-82","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/mol.113.089755","volume":"85","author":"Avery L.B.","year":"2014","unstructured":"Avery L.B.; Bumpus N.N.; Valproic acid is a novel activator of AMP-activated protein kinase and decreases liver mass, hepatic fat accumulation, and serum glucose in obese mice. Mol Pharmacol  2014,85(1),1-10","journal-title":"Mol Pharmacol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.toxlet.2018.04.021","volume":"292","author":"Lee H.C.","year":"2018","unstructured":"Lee H.C.; Liao C.C.; Day Y.J.; Liou J.T.; Li A.H.; Liu F.C.; IL-17 deficiency attenuates acetaminophen-induced hepatotoxicity in mice. Toxicol Lett  2018,292,20-30","journal-title":"Toxicol Lett"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.fct.2014.06.004","volume":"71","author":"Wang X.","year":"2014","unstructured":"Wang X.; Jiang Z.; Xing M.; Fu J.; Su Y.; Sun L.; Zhang L.; Interleukin-17 mediates triptolide-induced liver injury in mice. Food Chem Toxicol  2014,71,33-41","journal-title":"Food Chem Toxicol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"114264","DOI":"10.1016\/j.physbeh.2023.114264","volume":"269","author":"Barzegari A.","year":"2023","unstructured":"Barzegari A.; Amouzad Mahdirejei H.; Hanani M.; Esmaeili M.H.; Salari A.A.; Adolescent swimming exercise following maternal valproic acid treatment improves cognition and reduces stress-related symptoms in offspring mice: Role of sex and brain cytokines. Physiol Behav  2023,269,114264","journal-title":"Physiol Behav"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2174\/1871530320999200918120617","volume":"21","author":"A-G N.","year":"2021","unstructured":"A-G N.; am E.; Eh R.; Ahmed R.G.; Maternal Sodium Valproate Exposure Alters Neuroendocrine-Cytokines and Oxido-inflammatory Axes in Neonatal Albino Rats. Endocr Metab Immune Disord Drug Targets  2021,21(8),1491-1503","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cyto.2016.08.035","volume":"101","author":"Varfolomeev E.","year":"2018","unstructured":"Varfolomeev E.; Vucic D.; Intracellular regulation of TNF activity in health and disease. Cytokine  2018,101,26-32","journal-title":"Cytokine"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.joen.2023.07.013","volume":"49","author":"Almeida-Junior \u00a0 L.A.","year":"2023","unstructured":"Almeida-Junior \u00a0 L.A.; de Carvalho \u00a0 M.S.; Almeida L.K.Y.; Silva-Sousa A.C.; Sousa-Neto M.D.; Silva R.A.B.; Silva L.A.B.; Paula-Silva F.W.G.; TNF-\u03b1\u2013TNFR1 signaling mediates inflammation and bone resorption in apical periodontitis. J Endod  2023,49(10),1319-1328.e2","journal-title":"J Endod"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","volume":"35","author":"Wu L.","year":"2023","unstructured":"Wu L.; Jin Y.; Zhao X.; Tang K.; Zhao Y.; Tong L.; Yu X.; Xiong K.; Luo C.; Zhu J.; Wang F.; Zeng Z.; Pan D.; Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1. Cell Metab  2023,35(9),1580-1596.e9","journal-title":"Cell Metab"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41419-023-06014-5","volume":"14","author":"Harit K.","year":"2023","unstructured":"Harit K.; Bhattacharjee R.; Matuschewski K.; Becker J.; Kalinke U.; Schl\u00fcter D.; Nishanth G.; The deubiquitinating enzyme OTUD7b protects dendritic cells from TNF-induced apoptosis by stabilizing the E3 ligase TRAF2. Cell Death Dis  2023,14(7),480","journal-title":"Cell Death Dis"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"108238","DOI":"10.1016\/j.pharmthera.2022.108238","volume":"237","author":"Cai J.","year":"2022","unstructured":"Cai J.; Rimal B.; Jiang C.; Chiang J.Y.L.; Patterson A.D.; Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Ther  2022,237,108238","journal-title":"Pharmacol Ther"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s11427-023-2353-0","volume":"67","author":"Jia W.","year":"2024","unstructured":"Jia W.; Li Y.; Cheung K.C.P.; Zheng X.; Bile acid signaling in the regulation of whole body metabolic and immunological homeostasis. Sci China Life Sci  2024,67(5),865-878","journal-title":"Sci China Life Sci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s11739-023-03343-3","volume":"18","author":"Di Ciaula A.","year":"2023","unstructured":"Di Ciaula A.; Bonfrate L.; Khalil M.; Portincasa P.; The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease. Intern Emerg Med  2023,18(8),2181-2197","journal-title":"Intern Emerg Med"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"BSR20212791","DOI":"10.1042\/BSR20212791","volume":"43","author":"Jose S.","year":"2023","unstructured":"Jose S.; Devi S.S.; Sajeev A.; Girisa S.; Alqahtani M.S.; Abbas M.; Alshammari A.; Sethi G.; Kunnumakkara A.B.; Repurposing FDA-approved drugs as FXR agonists: A structure based in silico pharmacological study. Biosci Rep  2023,43(3),BSR20212791","journal-title":"Biosci Rep"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"106442","DOI":"10.1016\/j.intimp.2020.106442","volume":"83","author":"Zhang C.","year":"2020","unstructured":"Zhang C.; Gan Y.; Lv J.W.; Qin M.Q.; Hu W.R.; Liu Z.B.; Ma L.; Song B.D.; Li J.; Jiang W.Y.; Wang J.Q.; Wang H.; Xu D.X.; The protective effect of obeticholic acid on lipopolysaccharide-induced disorder of maternal bile acid metabolism in pregnant mice. Int Immunopharmacol  2020,83,106442","journal-title":"Int Immunopharmacol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3390\/ijms21062061","volume":"21","author":"Wang Y.","year":"2020","unstructured":"Wang Y.; Nakajima T.; Gonzalez F.J.; Tanaka N.; PPARs as metabolic regulators in the liver: Lessons from Liver-Specific PPAR-Null Mice. Int J Mol Sci  2020,21(6),2061","journal-title":"Int J Mol Sci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.tips.2023.11.004","volume":"45","author":"Titus C.","year":"2024","unstructured":"Titus C.; Hoque M.T.; Bendayan R.; PPAR agonists for the treatment of neuroinflammatory diseases. Trends Pharmacol Sci  2024,45(1),9-23","journal-title":"Trends Pharmacol Sci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1210\/me.2002-0120","volume":"17","author":"Pineda Torra I.","year":"2003","unstructured":"Pineda Torra I.; Claudel T.; Duval C.; Kosykh V.; Fruchart J.C.; Staels B.; Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Mol Endocrinol  2003,17(2),259-272","journal-title":"Mol Endocrinol"}],"container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734099324138240823041016","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/233673\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734099324138240823041016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T15:16:27Z","timestamp":1768230987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/233673\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734099324138240823041016","relation":{},"ISSN":["1573-4099"],"issn-type":[{"value":"1573-4099","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-05-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}